Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).
NCT07430501 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 7720
Last updated 2026-02-24
Summary
The goal of this observational study is to create a detailed virtual model to better understand how Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) develops. This model will also help predict heart problem at different stage of the disease.
Conditions
- Metabolic Dysfunction-Associated Steatotic Liver Disease
Interventions
- OTHER
-
Data recollection
Only data recollection for their use in the training, testing and early validation of computational models (but no other intervention) will be performed.
Sponsors & Collaborators
-
Matical Innovation SL
collaborator UNKNOWN -
Assistance Publique - Hôpitaux de Paris
collaborator OTHER -
Jena University Hospital
collaborator OTHER -
Institut National de Recherche en Informatique et Automatique
collaborator UNKNOWN -
German Cancer Research Center
collaborator OTHER -
MEDEX
collaborator OTHER -
EUROPEAN LIVER PATIENTS ASSOCIATION
collaborator UNKNOWN -
Betthera s.r.o.
collaborator OTHER -
Bournemouth University
collaborator OTHER -
University Hospital Heidelberg
collaborator OTHER -
Fundacion Para La Investigacion Hospital La Fe
collaborator OTHER -
University of Roma La Sapienza
collaborator OTHER -
Charite University, Berlin, Germany
collaborator OTHER -
Medical University of Vienna
collaborator OTHER -
Saint-Luc University Hospital
collaborator UNKNOWN -
University of Freiburg
collaborator OTHER -
University of Leipzig
collaborator OTHER -
Sheba Medical Center
collaborator OTHER_GOV -
Imperial College London
collaborator OTHER -
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-23
- Primary Completion
- 2026-06-02
- Completion
- 2027-09-02
Countries
- Spain
Study Locations
More Related Trials
-
Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
NCT06879236 ·Status: RECRUITING
-
Multicenter Registry of Nonalcoholic Fatty Liver Disease
NCT04540731 ·Status: NOT_YET_RECRUITING
-
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
NCT04782050 ·Status: COMPLETED ·Phase: NA
-
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease
NCT04220450 ·Status: UNKNOWN
-
Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease
NCT02488941 ·Status: UNKNOWN
-
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease
NCT03245606 ·Status: COMPLETED
-
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
NCT04191044 ·Status: UNKNOWN
-
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
NCT06661655 ·Status: RECRUITING ·Phase: NA
-
Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data
NCT06317181 ·Status: RECRUITING ·Phase: NA
-
Prognostic Model for MASLD Related Cirrhosis
NCT07082751 ·Status: NOT_YET_RECRUITING
-
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
NCT04578301 ·Status: RECRUITING
-
Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
NCT07192159 ·Status: RECRUITING ·Phase: NA
-
Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
NCT06907563 ·Status: NOT_YET_RECRUITING
-
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
NCT04099147 ·Status: UNKNOWN
-
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
NCT06814600 ·Status: RECRUITING
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
NCT07291141 ·Status: RECRUITING
-
Predicting Complications of Hepatolithiasis After Hepatectomy
NCT05556434 ·Status: UNKNOWN
-
Repeatability and Reproducibility of Multiparametric MRI
NCT03743272 ·Status: COMPLETED
-
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
NCT04435054 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis
NCT03746210 ·Status: RECRUITING
-
Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER
NCT04165343 ·Status: COMPLETED
-
Economic Burden of NAFLD
NCT05035043 ·Status: COMPLETED ·Phase: NA
-
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
NCT04802954 ·Status: COMPLETED ·Phase: NA
-
Comparison of MRI-PDFF to TAEUS FLIP Device to Estimate Liver Fat Fraction in Adults
NCT06373536 ·Status: NOT_YET_RECRUITING